Stock Options and Warrants - Schedule of Options and Warrants Outstanding (Details) - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Schedule of Options and Warrants Outstanding [Line Items] | |||
| Options Exercisable (in Shares) | 342,894,499 | 259,894,499 | |
| Weighted Average Exercise Price of Options Exercisable (in Dollars per share) | $ 0.012 | $ 0.011 | |
| Weighted Average Contractual Life of Options Exercisable (Years) | 3 years 10 months 13 days | 1 year 3 months 21 days | |
| Weighted Average Contractual Life of Options Outstanding (Years) | 3 years 11 months 12 days | 3 years 10 months 13 days | |
| Warrant [Member] | |||
| Schedule of Options and Warrants Outstanding [Line Items] | |||
| Warrants Exercisable (in Shares) | 78,095,239 | 78,095,239 | |
| Weighted Average Contractual Life of Warrants Outstanding and Exercisable (Years) | 8 months 1 day | ||
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for equity-based award excluding option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for exercisable stock option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for outstanding stock option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|